DSM-Firmenich revenue and financials
€99.68Change from previous close: +0.06%Absolute change: +€0.06
In the fiscal year ended December 2025, DSM-Firmenich reported revenue of €9.03B (−0.22% year over year). The net loss was €1.08B.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −0.22%
- 2025 vs 2024
- Net margin
- -12.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|---|
| Operating cash flow | 497 | 292 | 480 | 293 | 299 |
| Depreciation and amortization | 465 | 580 | 595 | 414 | 296 |
| Capital expenditure | -462 | -401 | -337 | -322 | -301 |
| Investing cash flow | -461 | 968 | -415 | -568 | -646 |
| Financing cash flow | 427 | -1,040 | -1,578 | 435 | -437 |
| Dividends paid | -624 | -713 | -661 | -6.0 | -172 |
| Share repurchases | -284 | -405 | -468 | -256 | -210 |
| Debt issued | 1,492 | 239 | 160 | 18.0 | — |
| Debt repaid | -58.0 | -53.0 | -553 | -34.0 | -29.0 |
| Effect of exchange rates | 17.0 | -66.0 | 27.0 | -17.0 | 15.0 |
| Net change in cash | 479 | 154 | -1,486 | 143 | -769 |
| Free cash flow | 35.0 | -109 | 143 | -29.0 | -2.0 |
| Levered free cash flow | -357 | -249 | -325 | -728 | -1,054 |